Former Ro director launches Allara, a care platform for PCOS

Rachel Blank has a history with hormones. The entrepreneur left her investment job at General Catalyst to join a portfolio company they had been backing since its seed round: Ro. Blank was tasked with growing Rory, a product line for menopausal women. But Blank left her director position at the health tech unicorn, last valued at $5 billion, to start…
« Previous post: | Next post: »